Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,145.00    145.00 (2.42%)
Bid:
6,145.00
Ask:
6,150.00
Spread: 5.00 (0.081%)
Market Cap: £5.25b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Board Changes

19 May 2026 07:05

RNS Number : 8033E
DCC PLC
19 May 2026
 

19 May 2026

 

Board Changes, includingWorkforce Engagement Director Appointment

DCC plc, the international energy group, today announces a number of changes to the Board.

Retirement of Mr Mark Ryan and appointment of Mr Steven Holland as Workforce Engagement Director

Mr Mark Ryan, the current Workforce Engagement Director, will, as announced in June 2025, retire from the Board at the conclusion of the Company's AGM on 16 July 2026. Following Mr Ryan's retirement, the Board has approved the appointment of Mr Steven Holland, currently a non‑executive Director, to the role of Workforce Engagement Director under Provision 5 of the UK Corporate Governance Code. 

Mr Holland has over 30 years' experience in the chemical distribution industry. He was appointed to the DCC Board in 2024. His industry experience and leadership background make him ideally suited to this important governance role.

Retirement of Ms Laura Angelini

Ms Laura Angelini will also retire as a non‑executive Director at the conclusion of the Company's AGM on 16 July 2026. Ms Angelini, appointed in 2021, has contributed deep healthcare sector expertise to the Board drawing on over 25 years of experience in medical devices and senior leadership roles at Baxter and Johnson & Johnson. 

Commenting on the Board changes, Mark Breuer, Chair of DCC plc, said:

"I wish to thank both Mark Ryan and Laura Angelini for their significant contributions to the Board of DCC. I am pleased that Steven Holland has agreed to take on the role of Workforce Engagement Director, a position that is vital to ensuring that the voice of our people continues to be represented at Board level."

 

 

 

Contact information

Investor enquiries:

 

Darragh Byrne, Company Secretary

Tel: +353 1 2799 400

Hollie Daly, Director of Investor Relations

Email: investorrelations@dcc.ie

Media enquiries:

Sodali & Co (Eavan Gannon/Pete Lambie)

Tel: +44 20 7250 1446

Email: DCCGroup@sodali.com

About DCC plc

DCC plc is a leader in multi-energy sales and distribution in Europe and the US.

We serve millions of customers across the commercial & industrial, public and domestic sectors. We deliver mainly off-grid energy solutions, led by liquid gas, and operate services stations and fleet services. We supply the secure, cleaner and competitive energy our customers need, supporting industrial processes, heating homes, and keeping transport moving. We do this while supporting customers through the transition with the energy and services they need next.

Headquartered in Dublin, DCC is listed on the London Stock Exchange and is a constituent of the FTSE 100. In our financial year ended 31 March 2026, DCC generated revenues of £15.4 billion and adjusted operating profit of £634.0 million. DCC Energy has an excellent record, delivering compound annual growth of 14% in adjusted operating profit and unbroken dividend growth of 13% while maintaining high returns on capital employed over 32 years as a public company.

Follow us on LinkedIn.www.dcc.ie

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWAKRNAUVAAR
Date   Source Headline
6th Oct 20203:40 pmRNSHolding in Company TR-1
5th Oct 202012:29 pmRNSHolding in Company TR-1
5th Oct 20209:30 amRNSHolding in Company TR-1
1st Oct 20205:07 pmRNSHolding in Company TR-1
22nd Sep 20204:29 pmRNSHolding in Company TR-1
21st Sep 20207:00 amRNSDCC expands LPG business in the US and Netherlands
9th Sep 20203:18 pmRNSAppointment of General Counsel & Company Secretary
4th Sep 20204:10 pmRNSUpdate on LTIP Performance Condition Ranges
31st Jul 202012:52 pmRNSTotal Voting Rights
23rd Jul 20204:14 pmRNSHolding in Company TR-1
21st Jul 202011:42 amRNSDirector/PDMR Shareholding
20th Jul 20204:00 pmRNSHolding in Company TR-1
17th Jul 20201:59 pmRNSResult of AGM
17th Jul 20207:00 amRNSInterim Management Statement
14th Jul 20202:28 pmRNSHolding in Company TR-1
8th Jul 202011:38 amRNSHolding in Company TR-1
24th Jun 20209:39 amRNSHolding in Company TR-1
18th Jun 202012:25 pmRNS2020 Annual Report, Notice of AGM and Proxy Form
3rd Jun 202010:10 amRNSHolding in Company TR-1
29th May 202011:27 amRNSTotal Voting Rights
28th May 20206:21 pmRNSDirector/PDMR Shareholding
28th May 20201:02 pmRNSHolding in Company TR-1
19th May 20205:04 pmRNSBoard Changes
19th May 20207:00 amRNSResults for the year ended 31 March 2020
14th May 20203:30 pmRNSHolding in Company TR-1
27th Apr 20206:02 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20204:24 pmRNSDirector Declaration
9th Apr 20204:21 pmRNSHolding in Company TR-1
3rd Apr 20204:01 pmRNSHolding in Company TR-1
25th Mar 20203:22 pmRNSHolding in Company TR-1
25th Mar 20207:00 amRNSDCC Healthcare announces acquisition of Amerilab
19th Mar 20204:10 pmRNSHolding in Company TR-1
19th Mar 20209:46 amRNSHolding in Company TR-1
18th Mar 202012:14 pmRNSHolding in Company TR-1
6th Mar 20204:08 pmRNSHolding in Company TR-1
28th Feb 202010:54 amRNSTotal Voting Rights
24th Feb 20208:38 amRNSBoard Change
24th Feb 20208:34 amRNSChief Financial Officer Succession
12th Feb 20209:10 amRNSHolding in Company TR-1
4th Feb 20207:00 amRNSInterim Management Statement
17th Jan 20209:23 amRNSHolding in Company TR-1
3rd Jan 202010:03 amRNSHolding in Company - TR1
23rd Dec 201912:44 pmRNSHolding in Company TR-1
5th Dec 20195:44 pmRNSHolding in Company - TR1
29th Nov 20191:39 pmRNSTotal Voting Rights
27th Nov 20199:18 amRNSDirector Declaration
18th Nov 20196:14 pmRNSDirector/PDMR Shareholding
12th Nov 20197:00 amRNSResults for the six months ended 30 September 2019
12th Nov 20197:00 amRNSDCC Healthcare acquires Ion Laboratories
7th Nov 201911:30 amRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.